Global Oligonucleotide (Oligo) Drugs Market Growth 2024-2030

Global Oligonucleotide (Oligo) Drugs Market Growth 2024-2030

Oligonucleotides (oligonucleotides for short) drugs are a type of drug molecules based on oligonucleotide structures, used to treat specific diseases. These drugs take advantage of the sequence selectivity, biomolecule recognition, and gene expression regulation of oligonucleotides to regulate the biological processes of diseases.

The global Oligonucleotide (Oligo) Drugs market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Oligonucleotide (Oligo) Drugs Industry Forecast” looks at past sales and reviews total world Oligonucleotide (Oligo) Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Oligonucleotide (Oligo) Drugs sales for 2024 through 2030. With Oligonucleotide (Oligo) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide (Oligo) Drugs industry.

This Insight Report provides a comprehensive analysis of the global Oligonucleotide (Oligo) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide (Oligo) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oligonucleotide (Oligo) Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide (Oligo) Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide (Oligo) Drugs.

United States market for Oligonucleotide (Oligo) Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Oligonucleotide (Oligo) Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Oligonucleotide (Oligo) Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Oligonucleotide (Oligo) Drugs players cover Lonis, Biogen, Sarepta, Novartis and Antisense Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide (Oligo) Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
siRNA
Antisense Oligonucleotide

Segmentation by application
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonis
Biogen
Sarepta
Novartis
Antisense Therapeutics
Akcea
Ruibo Biotechnology
Inois
Therapeutics Inc.
Sanofi

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oligonucleotide (Oligo) Drugs market?

What factors are driving Oligonucleotide (Oligo) Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oligonucleotide (Oligo) Drugs market opportunities vary by end market size?

How does Oligonucleotide (Oligo) Drugs break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.